GSK: AGREED TO SELL 385,320,110 ORDINARY SHARES IN HALEON AT A PRICE OF 324 PENCE PER SHARE RAISING GROSS PROCEEDS OF APPROXIMATELY £1,248M
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,610 GBX | +0.31% | -1.83% | +11.02% |
12:06pm | REGENXBIO Inc. Announces Chief Executive Officer Changes | CI |
12/06 | Moderna's RSV Vaccine Has 'Ample Opportunity' Despite Seasoned Competitors, Oppenheimer Says | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.02% | 84.04B | |
+50.32% | 781B | |
-7.32% | 350B | |
+18.68% | 330B | |
+7.15% | 293B | |
+16.91% | 248B | |
+0.53% | 221B | |
+11.06% | 217B | |
+3.49% | 162B | |
-4.05% | 157B |
- Stock Market
- Equities
- GSK Stock
- News GSK plc
- Gsk: Agreed To Sell 385,320,110 Ordinary Shares In Haleon At A P…